Basit öğe kaydını göster

dc.contributor.authorGurses, Candan
dc.contributor.authorEkizoglu, Esme
dc.contributor.authorTuzun, Erdem
dc.contributor.authorBaykan, BETÜL
dc.contributor.authorBebek, Nerses
dc.contributor.authorWoodhall, Mark
dc.contributor.authorLang, Bethan
dc.contributor.authorJacobson, Leslie
dc.contributor.authorIcoz, Sema
dc.contributor.authorGokyigit, Aysen
dc.contributor.authorWaters, Patrick
dc.contributor.authorVincent, Angela
dc.date.accessioned2021-03-03T10:55:34Z
dc.date.available2021-03-03T10:55:34Z
dc.date.issued2014
dc.identifier.citationEkizoglu E., Tuzun E., Woodhall M., Lang B., Jacobson L., Icoz S., Bebek N., Gurses C., Gokyigit A., Waters P., et al., "Investigation of neuronal autoantibodies in two different focal epilepsy syndromes", EPILEPSIA, cilt.55, sa.3, ss.414-422, 2014
dc.identifier.issn0013-9580
dc.identifier.othervv_1032021
dc.identifier.otherav_255d33a5-418a-4ea9-b07d-4b40112a0c4b
dc.identifier.urihttp://hdl.handle.net/20.500.12627/30009
dc.identifier.urihttps://doi.org/10.1111/epi.12528
dc.description.abstractObjectiveNeuronal antibodies have been identified in patients with seizures as the main or sole symptom. Our aim was to investigate the prevalence of these autoantibodies in patients with focal epilepsy of unknown cause (FEoUC) and in the group having mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS).
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectKLİNİK NEUROLOJİ
dc.subjectTıp
dc.subjectDahili Tıp Bilimleri
dc.subjectNöroloji
dc.titleInvestigation of neuronal autoantibodies in two different focal epilepsy syndromes
dc.typeMakale
dc.relation.journalEPILEPSIA
dc.contributor.departmentUniversity Of Oxford , ,
dc.identifier.volume55
dc.identifier.issue3
dc.identifier.startpage414
dc.identifier.endpage422
dc.contributor.firstauthorID1870


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster